Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Approvals
FDA Approves Eli Lilly and Company (LLY)'s Once-Weekly Diabetes Drug 9/18/2014 4:20:27 PM
Auxilium Pharmaceuticals (AUXL), VIVUS, Inc. (VVUS)'s Faster-Acting Erectile Dysfunction Drug Wins FDA Approval 9/18/2014 6:15:22 AM
EPIRUS’ Remicade® Biosimilar Receives Final Approvals In India 9/16/2014 9:29:10 AM
FDA Approves AstraZeneca PLC (AZN), Nektar Therapeutics (CA) (NKTR)'s MOVANTIK™ For Opioid-Induced Constipation 9/16/2014 12:45:25 PM
FDA Approves Baxter International, Inc. (BAX), Halozyme Therapeutics, Inc. (HALO)'s HYQVIA 9/15/2014 6:15:03 AM
FDA Approves Orexigen Therapeutics, Inc. (OREX)'s Long-Awaited Weight Loss Drug Contrave 9/11/2014 5:59:03 AM
Lannett Company, Inc. (LCI) Receives FDA Approval For Oxycodone Hydrochloride Oral Solution USP, 100 mg Per 5 mL 9/11/2014 10:53:06 AM
FDA Approves Keryx Biopharmaceuticals (KERX)' Kidney Drug Ferric Citrate With Warnings, Shares Crash 9/8/2014 6:25:46 AM
ThromboGenics NV (TBGNF)' JETREA® Gains Approval In South Korea 9/8/2014 7:44:45 AM
FDA Approves Merck & Co., Inc. (MRK)'s New-Kind Of Cancer Drug Keytruda 9/4/2014 1:17:34 PM
DS Healthcare Group Obtains Regulatory Approval In Middle East 9/4/2014 9:15:06 AM
China’s Food And Drug Administration Has Cleared NovaBay Pharmaceuticals, Inc. (NBY)’s Neutrophase Skin And Wound Cleanser For Sale Throughout Mainland China By NovoBay’s Partner, China Pioneer Pharma 9/3/2014 1:34:43 PM
Allergan Inc. (AGN) Announces OZURDEX® (Dexamethasone 700 Mcg Intravitreal Implant In Applicator) Now Approved In The European Union For The Treatment Of Diabetic Macular Edema 9/2/2014 11:16:42 AM
New Indication For VIMPAT® (Lacosamide): UCB Group (UCBJF.PK)'s Anti-Epileptic Drug Approved By FDA As Monotherapy In The Treatment Of Patients With Partial-Onset Seizures 9/2/2014 11:37:51 AM
GE Healthcare Announces European Union Approval Of VIZAMYL™ (Flutemetamol (18F) Solution For Injection) For PET Imaging Of Beta Amyloid Plaque In Suspected Alzheimer’s Disease 9/2/2014 12:06:11 PM
1234567
//-->